Patents by Inventor Thierry Imbert

Thierry Imbert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9439982
    Abstract: The invention relates to fluorescent derivatives of cyanines conjugated with a polyamine group, having formula (I), or a pharmaceutically acceptable salt thereof. The invention also relates to the method for preparing said derivatives, diagnostic compositions containing same and the use thereof as a diagnostic probe for the detection of cancer tumors, in particular in vivo.
    Type: Grant
    Filed: November 24, 2011
    Date of Patent: September 13, 2016
    Assignees: PIERRE FABRE MEDICAMENT, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
    Inventors: Yves Guminski, Thierry Imbert, Sabrina Pesnel, Arnaud Pillon, Alain Le Pape, Stephanie Lerondel
  • Patent number: 9403840
    Abstract: The present invention relates to novel podophyllotoxin derivatives substituted in the 4-position by a substituted (poly)aminoalkylaminoacetamide chain, to their process of preparation and to their use as medicament as anticancer agents.
    Type: Grant
    Filed: September 1, 2015
    Date of Patent: August 2, 2016
    Assignee: PIERRE FABRE MEDICAMENT
    Inventors: Thierry Imbert, Yves Guminski, Jean-Marc Barret, Anna Kruczynski
  • Publication number: 20150368258
    Abstract: The present invention relates to novel podophyllotoxin derivatives substituted in the 4-position by a substituted (poly)aminoalkylaminoacetamide chain, to their process of preparation and to their use as medicament as anticancer agents.
    Type: Application
    Filed: September 1, 2015
    Publication date: December 24, 2015
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: Thierry IMBERT, Yves GUMINSKI, Jean-Marc BARRET, Anna KRUCZYNSKI
  • Patent number: 9216989
    Abstract: The present invention relates to novel podophyllotoxin derivatives substituted in the 4-position by a substituted (poly)aminoalkylaminoacetamide chain, to their process of preparation and to their use as medicament as anticancer agents.
    Type: Grant
    Filed: November 10, 2010
    Date of Patent: December 22, 2015
    Assignee: PIERRE FABRE MEDICAMENT
    Inventors: Thierry Imbert, Yves Guminski, Jean-Marc Barret, Anna Kruczynski
  • Publication number: 20150336943
    Abstract: The present invention concerns benzodioxane-piperidine with general formula I: wherein notably: R1 represents one or more identical or different substituent(s) on the benzene ring, each independently representing a hydrogen or halogen atom, or a C1-4 alkyl group, or a C1-4 alkoxy group or a C1-4 hydroxyalkyl group or a C1-4 alkylcarbonyl or an alkoxycarbonyl group or an OH group or an SO2R group with R alkyl, or a CN group, or a CF3 group, or an OCF 3 group; n=1, 2 or 3; m=0 or 1, and R2 represents one or more identical or different substituent(s) on the oxazolidinone or morpholinone ring, each independently representing: a hydrogen atom, a C1-4 alkyl group, or a C1-4 alkoxy group, or a C1-4 hydroxyalkyl group, or an alkylcarbonyl group, or an alkoxycarbonyl group, or an alkoxyphenyl group.
    Type: Application
    Filed: January 7, 2014
    Publication date: November 26, 2015
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: Pierre SOKOLOFF, Philippe MAILLOS, Florence CUISIAT, Jean-Louis VIDALUC, Thierry IMBERT
  • Patent number: 8664409
    Abstract: The present invention relates to a new process for the preparation of (poly)aminoalkylaminoacetamide derivatives of epipodophyllotoxin and salts thereof, characterized in that it comprises a step of peptide coupling of 4-amino-4?-demethylepipodophyllotoxin with an amine-containing reactant having protecting groups.
    Type: Grant
    Filed: September 23, 2008
    Date of Patent: March 4, 2014
    Assignee: Pierre Fabre Medicament
    Inventors: Yves Guminski, Martial Grousseaud, Thierry Imbert
  • Patent number: 8569011
    Abstract: The invention relates to novel fluorescent derivatives of polyamines having a benzoxadiazole group, to a method for preparing the same and to the use thereof as diagnosis tools for emphasising the polyamine transport system in cancerous cells in order to adapt the treatment thereof, and thus for selecting patients carrying such tumors in order to adapt their treatment. The derivatives are of the formula (I) or a pharmaceutically acceptable salt thereof, in which: R1 is one or more NO2 groups in position 4 or 6, or a SO2Ph, SO2NMe2, SO2NH2 or SO3H group; R2 is hydrogen, C1-6 alkyl, benzyl, a perfluoroalkyl group; the values of a, b, c range from 2 to 5 independently from each other and represent alkylene chains separating the amino groups, and the values of d and e can independently be 0 or 1.
    Type: Grant
    Filed: June 11, 2012
    Date of Patent: October 29, 2013
    Assignee: Pierre Fabre Medicament
    Inventors: Jean-Philippe Annereau, Jean-Marc Barret, Yves Guminski, Thierry Imbert
  • Patent number: 8546402
    Abstract: The present invention relates to chromone derivatives, their preparation, their pharmaceutical compositions and their application as D3 dopaminergic ligands as a medicament for disorders of the central nervous system.
    Type: Grant
    Filed: August 31, 2010
    Date of Patent: October 1, 2013
    Inventors: Pierre Sokoloff, Thierry Imbert, Ludovic Leriche, Jean-François Patoiseau, Jean-Pierre Rieu
  • Patent number: 8492567
    Abstract: The present invention relates to new derivatives of epipodophyllotoxin 4-substituted with an optionally substituted (poly)aminoalkylaminoalkylamide, or alkyl-urea or alkyl-sulfonamide chain, a process for preparing them and their use as a medicine as an anticancer agent.
    Type: Grant
    Filed: July 17, 2012
    Date of Patent: July 23, 2013
    Assignee: Pierre Fabre Medicament
    Inventors: Thierry Imbert, Yves Guminski, Jean-Marc Barret, Anna Kruczynski
  • Publication number: 20130183247
    Abstract: The invention relates to fluorescent derivatives of cyanines conjugated with a polyamine group, having formula (I), or a pharmaceutically acceptable salt thereof. The invention also relates to the method for preparing said derivatives, diagnostic compositions containing same and the use thereof as a diagnostic probe for the detection of cancer tumours, in particular in vivo.
    Type: Application
    Filed: November 24, 2011
    Publication date: July 18, 2013
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), PIERRE FABRE MEDICAMENT
    Inventors: Yves Guminski, Thierry Imbert, Sabrina Pesnel, Arnaud Pillon, Alain Le Pape, Stephanie Lerondel
  • Publication number: 20130171067
    Abstract: The invention relates to a compound having formula (I), compositions containing same and preparation methods thereof. The invention also relates to a complex of the compound having formula (I) with technetium-99m and tricine, the use of this complex as a diagnostic probe, diagnostic compositions containing same and methods for preparing the complex and compositions containing same.
    Type: Application
    Filed: November 24, 2011
    Publication date: July 4, 2013
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: Yves Guminski, Thierry Imbert, Sabrina Pesnel, Nicolas Guilbaud, Alain Le Pape, Stéphanie Lerondel
  • Publication number: 20120283281
    Abstract: The present invention relates to new derivatives of epipodophyllotoxin 4-substituted with an optionally substituted (poly)aminoalkylaminoalkylamide, or alkyl-urea or alkyl-sulfonamide chain, a process for preparing them and their use as a medicine as an anticancer agent.
    Type: Application
    Filed: July 17, 2012
    Publication date: November 8, 2012
    Inventors: Thierry IMBERT, Yves GUMINSKI, Jean-Marc BARRET, Anna KRUCZYNSKI
  • Patent number: 8288567
    Abstract: The present invention relates to new derivatives of epipodophyllotoxin 4-substituted with an optionally substituted (poly)aminoalkylaminoalkylamidc, or alkyl-urea or alkyl-sulfonamide chain, a process for preparing them and their use as a medicine as an anticancer agent. Formula (1) wherein: —R represents hydrogen or C1-4alkyl, —A represents CO(CH2)n or CONH(CH2)n where n=2, 3, 4, or 5, —R1 and R2 are as described herein.
    Type: Grant
    Filed: August 19, 2009
    Date of Patent: October 16, 2012
    Assignee: Pierre Fabre Medicament
    Inventors: Thierry Imbert, Yves Guminski, Jean-Marc Barret, Anna Kruczynski
  • Publication number: 20120252059
    Abstract: The invention relates to novel fluorescent derivatives of polyamines having a benzoxadiazole group, to a method for preparing the same and to the use thereof as diagnosis tools for emphasising the polyamine transport system in cancerous cells in order to adapt the treatment thereof, and thus for selecting patients carrying such tumours in order to adapt their treatment. The derivatives are of the formula (I) or a pharmaceutically acceptable salt thereof, in which: R1 is one or more NO2 groups in position 4 or 6, or a SO2Ph, SO2NMe2, SO2NH2 or SO3H group; R2 is hydrogen, C1-6 alkyl, benzyl, a perfluoroalkyl group; the values of a, b, c range from 2 to 5 independently from each other and represent alkylene chains separating the amino groups, and the values of d and e can independently be 0 or 1.
    Type: Application
    Filed: June 11, 2012
    Publication date: October 4, 2012
    Inventors: Jean-Philippe Annereau, Jean-Marc Barret, Yves Guminski, Thierry Imbert
  • Publication number: 20120157463
    Abstract: The present invention relates to chromone derivatives, their preparation, their pharmaceutical compositions and their application as D3 dopaminergic ligands as a medicament for disorders of the central nervous system.
    Type: Application
    Filed: August 31, 2010
    Publication date: June 21, 2012
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: Pierre Sokoloff, Thierry Imbert, Jean-François Patoiseau, Jean-Pierre Rieu
  • Patent number: 8193379
    Abstract: The invention relates to a method for synthesizing 4?-amino-4?-demethyl-4-desoxypodophyllotoxin of formula (1), characterized by comprising the following successive steps: a) reacting, in a pure weak acid or in a mixture consisting of acid, water and of organic solvent, without another solvent, at a temperature higher than the ambient temperature, thiourea with 4?-halogenoacetamido-4?-demethyl-4-desoxypodophyllotoxin, and; b) recovering the 4?-amino-4?-demethyl-4-desoxypodophyllotoxin.
    Type: Grant
    Filed: September 30, 2010
    Date of Patent: June 5, 2012
    Inventors: Yves Guminski, Martial Grousseaud, Thierry Imbert
  • Patent number: 8148552
    Abstract: The present invention describes a new process for the preparation of (poly)aminoalkylaminoacetamide compounds of epipodophyllotoxin useful for their applications in therapeutics as anticancer agents. This process comprises a step of condensation of a primary-amine-containing reactant, whose amine functions are not protected, with ?-chloroacetamido-4?-epipodophyllotoxin in a polar aprotic organic solvent.
    Type: Grant
    Filed: September 23, 2008
    Date of Patent: April 3, 2012
    Assignee: Pierre Fabre Medicament
    Inventors: Yves Guminski, Martial Grousseaud, Thierry Imbert
  • Publication number: 20120022273
    Abstract: The present invention relates to a new process for the preparation of (poly)aminoalkylaminoacetamide derivatives of epipodophyllotoxin and salts thereof, characterised in that it comprises a step of peptide coupling of 4-amino-4?-demethylepipodophyllotoxin with an amine-containing reactant having protecting groups.
    Type: Application
    Filed: September 23, 2008
    Publication date: January 26, 2012
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: Yves Guminski, Martial Grousseaud, Thierry Imbert
  • Publication number: 20110172257
    Abstract: The present invention relates to new derivatives of epipodophyllotoxin 4-substituted with an optionally substituted (poly)aminoalkylaminoalkylamide, or alkyl-urea or alkyl-sulfonamide chain, a process for preparing them and their use as a medicine as an anticancer agent. Formula (1) wherein: —R represents hydrogen or C1-4alkyl, —A represents CO(CH2)n or CONH(CH2)n where n=2, 3, 4, or 5, —R1 and R2 are as described herein.
    Type: Application
    Filed: August 19, 2009
    Publication date: July 14, 2011
    Inventors: Thierry Imbert, Yves Guminski, Jean-Marc Barret, Anna Kruczynski
  • Patent number: 7932406
    Abstract: The invention relates to a method for synthesizing 4.beta.-amino-4?-demethyl-4-desoxypodophyllotoxin of formula (1), characterized by comprising the following successive steps: a) reacting, in a pure weak acid or in a mixture consisting of acid, water and of organic solvent, without another solvent, at a temperature higher than the ambient temperature, thiourea with 4.beta.-halogenoacetamido-4?-demethyl-4-desoxypodophyllotoxin, and; b) recovering the 4.beta.-amino-4?-demethyl-4-desoxypodophyllotoxin.
    Type: Grant
    Filed: July 19, 2006
    Date of Patent: April 26, 2011
    Assignee: Pierre Fabre Medicament
    Inventors: Yves Guminski, Martial Grousseaud, Thierry Imbert